By Michael Irving October 23, 2023 A diabetes-delaying drug has shown promise in a new clinical trialDepositphotosA phase 3 clinical trial has shown that a drug called teplizumab can slow down progression of type 1 diabetes in children and teenagers with a recent diagnosis. The trial’s success could help expand the options for patients and relieve...
